Erratum:
PTEN
deletion drives acute myeloid leukemia resistance to MEK inhibitors
Oncotarget
.
2020 Jan 21;11(3):305.
doi: 10.18632/oncotarget.27402.
Authors
Amanda M Smith
#
1
2
,
Christine R C Zhang
#
1
2
,
Alexandre S Cristino
1
3
,
John P Grady
1
4
,
J Lynn Fink
1
,
Andrew S Moore
1
5
6
Affiliations
1
The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Australia.
2
Current address: Washington University in Saint Louis, Saint Louis, Missouri, United States of America.
3
Current address: Griffith Institute for Drug Discovery, Brisbane Innovation Park, Nathan, Australia.
4
Current address: Garvan Institute of Medical Research, Darlinghurst, Australia.
5
Oncology Services Group, Queensland Children's Hospital, South Brisbane, Australia.
6
Child Health Research Centre, The University of Queensland, South Brisbane, Australia.
#
Contributed equally.
PMID:
32076493
PMCID:
PMC6980628
DOI:
10.18632/oncotarget.27402
Abstract
[This corrects the article DOI: 10.18632/oncotarget.27206.].
Copyright: © 2019 Smith et al.
Publication types
Published Erratum